Catalog Products » SARS-CoV-2 Spike protein RBD-HRP, Omicron Variant, His Tag
SARS-CoV-2 Spike Protein RBD-HRP, Omicron Variant, His Tag

SARS-CoV-2 Spike protein RBD-HRP, Omicron Variant, His Tag (Cat.No. Z03730) can bind with ACE2 in functional ELISA assay.

SARS-CoV-2 Spike protein RBD-HRP, Omicron Variant, His Tag

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. Recently, the new B.1.1.529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant. The B.1.1.529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern), named Omicron. There are more than 30 mutations in the spike protein.
Z03730
$120.00

Ask us a question
Product Introduction
Species SARS-CoV-2
Protein Construction

Expressed with the mutations of G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H.

Spike RBD (Arg319-Phe541)
Accession # P0DTC2		 Poly-His
N-term C-term
Conjugate HRP
Biological Activity This protein is validated to bind with human ACE2 in functional ELISA assay.
Expression System Human Cells
Application The optimal dilution ratio should be determined by the end user for specific applications.
ELISA 1:1000
Formulation Supplied as a solution in PBS, pH 7.4, 0.1% ProClin 300.
Storage & Stability Upon receiving, this product remains stable for up to 3 months at 2-8 °C. Protect from light.

Examples
  • SARS-CoV-2 Spike Protein RBD-HRP, Omicron Variant, His Tag
    • SARS-CoV-2 Spike Protein RBD-HRP, Omicron Variant, His Tag

    SARS-CoV-2 Spike protein RBD-HRP, Omicron Variant, His Tag (Cat.No. Z03730) can bind with ACE2 in functional ELISA assay.


Background
Target Background SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. Recently, the new B.1.1.529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant. The B.1.1.529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern), named Omicron. There are more than 30 mutations in the spike protein.
Synonyms B.1.1.529; Omicron variant
References 1. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern.
2. Omicron: What Is Known — and Still Unknown.

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.


Do you like the current new website?

Hate

Dislike

Neutral

Like

Love

*
Skip